Skip to main content
. 2020 Nov 6;62:103078. doi: 10.1016/j.ebiom.2020.103078

Table 3.

Adjusted associations of genomic load categories with risks of clinically more severe outcomes for EV-A71 and CV-A6.

Outcome
Genomic load category*
EV-A71
CV-A6
Adjusted OR P value Adjusted OR P value
Diagnoses as CNS complications
 Low Reference Reference
 Medium 2.16 (0.93–4.99) 0.07 0.61 (0.25–1.46) 0.27
 High 3.42 (1.44–8.12) 0.005 1.06 (0.49–2.28) 0.89
Require special treatment
 Low Reference Reference
 Medium 2.23 (1.00–4.99) 0.05 2.50 (1.11–5.64) 0.03
 High 3.27 (1.42–7.51) 0.005 2.59 (1.16–5.81) 0.02
ICU admission
 Low Reference Reference
 Medium 3.26 (0.95–11.20) 0.06 NA§ NA§
 High 7.73 (2.25–26.53) 0.001 NA§ NA§
LOS over 5 days
 Low Reference Reference
 Medium 1.37 (0.61–3.07) 0.44 0.84 (0.45–1.56) 0.58
 High 2.57 (1.13–5.84) 0.02 1.36 (0.77–2.40) 0.29

Abbreviations: Ct, cycle threshold; OR, odds ratio; CNS, central nervous system; ICU, intensive care unit; LOS, length of stay.

Genomic load categories of EV-A71 were classified based on Ct values as follows: low,≥34.4; medium, 28.3–34.3; and high, <28.3. Genomic load categories of CV-A6 were classified based on Ct values as follows: low,≥31.2; medium, 26.7–31.1; and high, <26.7.

Odds ratio adjusted for age, residence type and parents’ highest education.

Defined as receiving systemic corticosteroids or IVIG during hospitalization.

§

No case of low genomic load admitted to ICU, thus no reliable model could be established.